The multiple uses of fluorescent proteins to visualize cancer in vivo
RM Hoffman - Nature Reviews Cancer, 2005 - nature.com
Naturally fluorescent proteins have revolutionized biology by enabling what was formerly
invisible to be seen clearly. These proteins have allowed us to visualize, in real time …
invisible to be seen clearly. These proteins have allowed us to visualize, in real time …
[HTML][HTML] Benefits of functional assays in personalized cancer medicine: More than just a proof-of-concept
CBM du Puch, M Vanderstraete, S Giraud… - Theranostics, 2021 - ncbi.nlm.nih.gov
As complex and heterogeneous diseases, cancers require a more tailored therapeutic
management than most pathologies. Recent advances in anticancer drug development …
management than most pathologies. Recent advances in anticancer drug development …
Gynecologic and breast cancers: what's new in chemoresistance and chemosensitivity tests?
JC Marcolin, M Lichtenfels, CA da Silva… - Current Problems in …, 2023 - Elsevier
Gynecological and breast cancers affect women's health worldwide. Although chemotherapy
is one of the principal treatments for cancer, it also has limitations owing to toxicity and tumor …
is one of the principal treatments for cancer, it also has limitations owing to toxicity and tumor …
[HTML][HTML] The identification of candidate effective combination regimens for pancreatic cancer using the histoculture drug response assay
The prognosis for patients with pancreatic cancer is extremely poor, as they are resistant to
first line chemotherapy. The long-term goal of this study was to identify effective combination …
first line chemotherapy. The long-term goal of this study was to identify effective combination …
Clinical significance of the histoculture drug response assay in breast cancer
Y Shinden, Y Kijima, M Hirata, H Arima… - Anticancer …, 2016 - ar.iiarjournals.org
Background/Aim: Despite the fact that breast cancer patients are generally administered
systemic chemotherapy after surgical treatment, predictive factors that allow optimization of …
systemic chemotherapy after surgical treatment, predictive factors that allow optimization of …
Predicting the risk of new cerebral lesions after stereotactic radiosurgery (SRS) for brain metastases from breast cancer
L Dziggel, M Dahlke, S Janssen, D Hornung… - Anticancer …, 2015 - ar.iiarjournals.org
Aim: To generate a tool that estimates the probability of developing new cerebral metastases
after stereotactic radiosurgery (SRS) in breast cancer patients. Patients and Methods: SRS …
after stereotactic radiosurgery (SRS) in breast cancer patients. Patients and Methods: SRS …
Collagen gel droplet-embedded culture drug sensitivity test for adjuvant chemotherapy after complete resection of non-small-cell lung cancer
M Inoue, H Maeda, Y Takeuchi, K Fukuhara, Y Shintani… - Surgery Today, 2018 - Springer
Purpose We conducted a prospective clinical study to individualize adjuvant chemotherapy
after complete resection of non-small-cell lung cancer (NSCLC), based on the drug …
after complete resection of non-small-cell lung cancer (NSCLC), based on the drug …
Clinical usefulness of the histoculture drug response assay for breast cancer
RM Hoffman, H Tanino - 3D Sponge-Matrix Histoculture: Methods and …, 2018 - Springer
The histoculture drug response assay (HDRA) was used to compare drug sensitivity of
recurrent and primary breast cancer in vitro as well as in the clinic. The HDRA utilizes 3 …
recurrent and primary breast cancer in vitro as well as in the clinic. The HDRA utilizes 3 …
Expression and Targeting of Tumor Markers in Gelfoam® Histoculture: Potential Individualized Assays for Immuno-Oncology
RM Hoffman, F Guadagni - 3D Sponge-Matrix Histoculture: Methods and …, 2018 - Springer
Tumor-specific antigens are important in the study of tumor biology, tumor diagnosis, and
prognosis and as targets for tumor therapy. This chapter reviews patient colon, breast, and …
prognosis and as targets for tumor therapy. This chapter reviews patient colon, breast, and …